WUZHOU MEDICAL’s Stock Surge Linked to Strategic Asset Transfer and Chip‑Industry Acquisition
On 22 July 2026, WUZHOU MEDICAL (stock code 301234, trading symbol “20CM”) was the first listed share of the day to reach the daily limit, trading at 40.8 CNY per share. The 40 % increase from the 7‑day closing price of 34 CNY created a new market capitalization of approximately 27.74 billion CNY, up from the prior‑closing market cap of 23.12 billion CNY.
1. Share Transfer by the Company’s Controlling Interest
In the evening of 21 July 2026, the company’s actual controller and his consistent‑action partners, together with several key natural‑person shareholders, signed a Share Transfer Agreement with Jiaxing Huixin Enterprise Management Partnership (Limited Partnership). The agreement covers 8.0288 million shares, representing 11.81 % of the total share capital. The transaction price of 48.5294 CNY per share amounts to a total consideration of ≈3.9 billion CNY. Because the last trading day before suspension (7 July) closed at 34 CNY, the transfer represents a ≈43 % premium over the pre‑suspension price, underscoring the significance of the deal for shareholders.
2. Planned Acquisition of XuanZhi Electronics Technology (Shanghai) Co., Ltd.
Simultaneously, WUZHOU MEDICAL announced its intention to acquire 100 % of XuanZhi Electronics Technology (Shanghai) Co., Ltd. (hereafter XuanZhi Tech). The acquisition will be financed by a combination of new share issuance and cash payment. XuanZhi Tech specializes in high‑integration motor‑control chips and offers a full‑stack solution—chip, algorithm, and system—for applications in smart equipment, household appliances, industrial control, and automotive electronics.
| Fiscal Year | Revenue (CNY) | Net Profit (CNY) |
|---|---|---|
| 2024 | 158 million | –41.85 million |
| 2025 | 258 million | 32.78 million |
| 2026 (H1) | 190 million | 20.91 million |
The acquisition is expected to diversify WUZHOU MEDICAL’s business beyond disposable sterile infusion devices, positioning it within the rapidly growing semiconductor sector.
3. Market Reaction and Broader Context
The share price jump coincided with a day in which 52 shares reached the limit‑up status. Among the sectors with the highest number of limit‑up stocks were electronics, non‑ferrous metals, and medical‑biological industries. Despite an overall low‑opening trend for the A‑share market (the Shanghai Composite Index opened down 0.64 %) and a 0.94 % rise in spot gold, WUZHOU MEDICAL’s strong first‑hand trading activity attracted significant attention. The limit‑up board attracted over 160,000 orders for the 20 CNY price level, indicating substantial institutional interest.
4. Financial Snapshot (as of 6 July 2026)
| Metric | Value |
|---|---|
| Closing price | 34 CNY |
| 52‑week high | 52.32 CNY |
| 52‑week low | 31.06 CNY |
| Market capitalization | 2,312,000,000 CNY |
| Price‑Earnings ratio | 106.9 |
The price‑earnings ratio reflects the market’s valuation of the company’s growth prospects, particularly after the announced diversification into semiconductors.
5. Conclusion
WUZHOU MEDICAL’s market‑capitalization surge on 22 July 2026 is directly attributable to its share‑transfer agreement and its planned acquisition of a high‑integration chip maker. These strategic moves signal a transition from a specialized medical device manufacturer to a broader technology firm, potentially reshaping the company’s competitive profile and investor expectations.
